CompletedNCT06620042
Brain imaging during ketamine care for bipolar depression
About this title
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
Read the official source — NCT06620042Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
What did participation involve?
The protocol includes: Having magnetic resonance imaging (MRI) scans.
- Listed locations
- Cleveland and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: November 12, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Drew Cumming
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06620042
- Official title
Show the full official title
Functional Magnetic Resonance Imaging of Patients Receiving Intravenous Ketamine for Treatment Resistant Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland · Ohio City
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to have MRI scans.
Who is behind this study?
The study sponsor is Drew Cumming.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 75 years.
